Incidence of PI3K pathway aberrations and their impact on response to neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC) subtypes

被引：0
|
作者：
Basho, Reva K.
Trevarton, Alex
Hess, Kenneth R.
Fu, Chunxiao
Lau, Rosanna
Lin, Chih-Hsu
Lichtarge, Olivier
Yang, Wei Tse
Symmans, William Fraser
Moulder, Stacy L.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
588
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Incidence of PI3K pathway alteration and response to neoadjuvant therapy (NAT) in triple negative breast cancer (TNBC) subtypes.
    Basho, Reva K.
    Yam, Clinton
    White, Jason B.
    Zhao, Li
    Huo, Lei
    Mittendorf, Elizabeth A.
    Thompson, Alastair Mark
    Litton, Jennifer Keating
    Arun, Banu
    Lim, Bora
    Valero, Vicente
    Tripathy, Debu
    Zhang, Jianhua
    Adrada, Beatriz E.
    Santiago, Lumarie
    Ravenberg, Elizabeth
    Moulder, Stacy L.
    Damodaran, Senthil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Targeting PI3K/AKT pathway in triple-negative breast cancer
    Delaloge, Suzette
    DeForceville, Louise
    LANCET ONCOLOGY, 2017, 18 (10): : 1293 - 1294
  • [3] Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes
    Basho, Reva K.
    Zhao, Li
    White, Jason B.
    Huo, Lei
    Bassett, Roland L.
    Mittendorf, Elizabeth A.
    Thompson, Alastair
    Litton, Jennifer K.
    Ueno, Naoto
    Arun, Banu
    Lim, Bora
    Valero, Vicente
    Tripathy, Debu
    Zhang, Jianhua
    Adrada, Beatriz E.
    Santiago, Lumarie
    Ravenberg, Elizabeth
    Seth, Sahil
    Yam, Clinton
    Moulder, Stacy L.
    Damodaran, Senthil
    JCO PRECISION ONCOLOGY, 2024, 8
  • [4] The impact of gut microbial composition on response to neoadjuvant chemotherapy (NACT) in early-stage triple negative breast cancer (TNBC).
    Abuhadra, Nour
    Chang, Chia-Chi
    Yam, Clinton
    White, Jason B.
    Ravenberg, Elizabeth
    Lim, Bora
    Ueno, Naoto T.
    Litton, Jennifer Keating
    Arun, Banu
    Damodaran, Senthil
    Murthy, Rashmi Krishna
    Ibrahim, Nuhad K.
    Hortobagyi, Gabriel N.
    Valero, Vicente
    Tripathy, Debu
    Thompson, Alastair Mark
    Mittendorf, Elizabeth A.
    Huo, Lei
    Moulder, Stacy L.
    Jenq, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [7] Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    Ricardo L. B. Costa
    Hyo Sook Han
    William J. Gradishar
    Breast Cancer Research and Treatment, 2018, 169 : 397 - 406
  • [8] Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    Costa, Ricardo L. B.
    Han, Hyo Sook
    Gradishar, William J.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (03) : 397 - 406
  • [9] Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway
    Park, Yeon Hee
    Jung, Hae Hyun
    Ahn, Jin Seok
    Im, Young-Hyuck
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 439 (02) : 275 - 279
  • [10] Novel tumor suppressor regulating the PI3K/AKT pathway in triple negative breast cancer (TNBC)
    Chan, Stefanie
    Smith, Emma
    Monti, Stefano
    Cardamone, M. Dafne
    Perissi, Valentina
    CANCER RESEARCH, 2020, 80 (04)
12345